Notice Type
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:


Product: Olopatadine
Active Ingredient: Olopatadine hydrochloride 1.11mg/mL
equivalent to olopatadine 1.0mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: FDC Limited, Aurangabad, India
Product: RiaSTAP
Active Ingredient: Fibrinogen 900mg-1300mg
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: CSL Behring (NZ) Limited
Manufacturer: CSL Behring GmbH, Marburg, Germany

Dated this 25th day of November 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).